Willam N Kelley
CIK 1204361 · last filed 2019-04-26
Willam N Kelley is a corporate insider who has filed 101 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for TRXC, was dated Apr 26, 2019. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $707.0K across reported positions. 48 SEC filings were submitted jointly with MERCK SHARP & DOHME LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BEC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ONE MERCK DRIVE
WHITEHOUSE STATION, X1 08889
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ASENSUS SURGICAL, INC. (TRXC) Delisted | Director | 6,980 | $4.08 | $28.5K | $77.1K | 8 | 2019-04-26 |
| GENVEC INC (GNVC) Delisted | Director | 7,550 | — | — | $0 | 10 | 2016-10-24 |
| MRK | Director | 4,311 | $143.63 | $619.2K | -$60.1K | 32 | 2012-04-03 |
| BEC | Director | 7,689 | $11.42 | $87.8K | -$1.26M | 47 | 2011-06-28 |
Recent Filings
101 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-04-26 | ASENSUS SURGICAL, INC. (TRXC) Delisted | Grant (A) | +20,380 | $0 | EDGAR |
| 2018-05-29 | ASENSUS SURGICAL, INC. (TRXC) Delisted | Grant (A) | +20,362 | $0 | EDGAR |
| 2017-08-09 | ASENSUS SURGICAL, INC. (TRXC) Delisted | Buy (P) | +30,000 | $21.2K | EDGAR |
| 2017-06-20 | — | Mixed | −7,550 | -$2 | |
| 2017-05-26 | ASENSUS SURGICAL, INC. (TRXC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-10-24 | GENVEC INC (GNVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-10 | ASENSUS SURGICAL, INC. (TRXC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-11-16 | ASENSUS SURGICAL, INC. (TRXC) Delisted | Buy (P) | +20,000 | $55.9K | EDGAR |
| 2015-11-16 | GENVEC INC (GNVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-08 | ASENSUS SURGICAL, INC. (TRXC) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.